Bristol-Myers Squibb to acquire Mirati for $4.8B

Bristol-Myers Squibb Company announced it will acquire Mirati Therapeutics Inc. for $58 per share in cash in a transaction that will amount to $4.8 billion. The deal is expected to clear the regulator…